APMA staff participated in the AMA National Advocacy Conference that focused on how to advance shared legislative priorities, including meaningful Medicare Physician Payment Reform, reducing administrative burdens caused by prior authorization, and protecting and strengthening access to Medicaid. Following policy briefings from members of Congress, CMS officials, and national health-care leaders, APMA staff took these priorities directly to meetings on Capitol Hill.
APMA’s advocacy impact is strengthened through active participation in the Alliance of Wound Care Stakeholders (Alliance). We are proud to share the Alliance’s 2025 Advocacy Impact Report, which highlights the collective progress made to advance fair reimbursement, appropriate coverage, and equitable patient access.
APMA adopted a formal position statement on artificial intelligence (AI) and submitted comments to HHS in response to its national Request for Information on the use of AI in clinical care. APMA emphasized that AI should support, not replace, physician judgment. We also raised concerns that opaque algorithms and broad datasets can lead to inappropriate denials, downcoding, and delays in patient care.
APMA continues to work closely with state components on legislative strategy, stakeholder engagement, testimony development, grassroots advocacy, and regulatory outreach across multiple states, including Tennessee, Massachusetts, and Mississippi. Several states are also actively considering adoption of the IPMLC, including Arizona, Florida, Iowa, Maryland, and Ohio.
Last week, CMS announced a moratorium on enrollment (and enrollment expansion) for certain medical supply companies. This enrollment moratorium affects medical supply companies whose principal function is to furnish DMEPOS supplies, which does not represent most physician suppliers.
In the MLN Connects Newsletter for February 26, CMS highlighted that it has identified fraud involving stolen Medicare Beneficiary Identifiers (MBIs) and is increasing monitoring of the Medicare Administrative Contractor (MAC) MBI lookup tool.
APMA recently submitted testimony to the Senate Committee on Aging for its hearing titled "The Doctor Is Out How Washington’s Rules Drove Physicians Out of Medicine," highlighting how excessive prior authorization requirements in Medicare Advantage are delaying care and increasing administrative burdens for podiatrists.
APMA submitted comments to the House Committee on Veterans' Affairs expressing concern that the ongoing VHA reorganization and recent workforce reductions are threatening veterans' access to timely foot and ankle care. With approximately 30,000 VA positions eliminated in 2025 and new staffing caps in place, shortages are straining critical limb-preservation programs and limiting care for clinically complex veterans.
Last week, CMS reminded practitioners in nine states that they are required to report postoperative evaluation and management visits provided to Medicare patients if the practitioner practices in a group of 10 or more practitioners.
Following sustained advocacy and multiple rounds of direct communication with CMS and the DME MACs, APMA has secured critical clarification regarding coverage criteria for therapeutic shoes for persons with diabetes. We have confirmed that co-signed notes are not required when specific documentation standards are met.
The Medicare Advance Beneficiary Notice of Noncoverage (ABN) form expired on January 31, but CMS and Medicare Administrative Contractors (MACs) have confirmed that providers should continue using the current version until an updated form is released.
Last week, APMA provided a letter of support as written testimony to the Maryland Podiatric Medical Association (MPMA) in advance of the Maryland Senate Finance Committee hearing on legislation (SB 333) to join the Interstate Podiatric Medical Licensure Compact (IPMLC). The testimony highlights how participation in the compact would strengthen Maryland’s podiatric workforce.
APMA joined other physician societies to sign onto a letter led by the American College of Surgeons in support of the Efficiency Adjustment Delay Act (HR 7520). The legislation would delay the “efficiency adjustment” finalized in the 2026 MPFS and prevent any future adjustments from being calculated with similar productivity metrics.
Telehealth flexibilities that expired on January 30 have been retroactively reinstated. Telehealth flexibilities will now be available through January 31, 2027. This means providers may again provide telehealth services with no geographic restrictions and patients may receive telehealth services from their home.
CMS announced that certain DMEPOS suppliers will be eligible for an exemption from prior authorization requirements. APMA views this as a positive development and a direct result of years of advocacy urging CMS to adopt a "gold carding" approach. However, CMS also announced that claims for HCPCS L1932 (ankle foot orthosis with a rigid anterior tibial section, total carbon fiber or equivalent material) submitted to a DME MAC will require prior authorization beginning on April 13.
APMA submitted comments to CMS and Acumen, LLC, pressing for changes to the draft 2027 Diabetic Disease MIPS Value Pathway (MVP) Candidate. While APMA generally supports the development of an additional MVP option, we urged CMS to make substantive changes to ensure the pathway actually reduces burden and allows podiatrists to succeed in MIPS.
Members can now watch the newest APMA webinar addressing how their practice can avoid a penalty for MIPS 2026. Additional resources have been posted on the MIPS 2026 Resource page, related to the Quality, Promoting Interoperability, and Improvement Activity performance categories.
On January 20, the Mississippi Podiatric Medical Association (MsPMA) hosted a successful Capitol Day at the Mississippi State Capitol, bringing podiatric physicians face to face with lawmakers to advance SB 2442, legislation to modernize podiatric scope of practice in the state. APMA President Brooke Bisbee, DPM, attended the event alongside MsPMA President Charles Caplis, DPM, and other Mississippi podiatric leaders, to underscore national support for the state's advocacy efforts.
APMA has formally called on the Medicare Payment Advisory Commission (MedPAC) to end its routine misclassification of podiatrists as non-physician practitioners in Medicare analyses and reports. Federal law is clear: Doctors of podiatric medicine are physicians under the Medicare statute. Despite this, MedPAC continues to group podiatrists with non-physician providers in influential publications, undermining the accuracy of its workforce, access, and payment analyses.
APMA submitted formal comments to CMS on the Contract Year 2027 Medicare Advantage and Part D Proposed Rule, urging the agency to preserve plan accountability measures that protect timely access to care. APMA expressed concern that proposed changes to the Star Ratings program could weaken incentives for MA plans to resolve denials promptly, especially at a time when prior authorization barriers remain widespread.